A consumer rights group in the Southeastern Asian nation of Malaysia filed a police report targeting the Health Ministry for failing to use ivermectin to prevent COVID-19. In an unprecedented action, the Malaysia Muslim Consumers Association (PPIM) issued a statement at a police headquarters in the Dang Wangi district in the nation’s largest city of Kuala Lumpur. Led by Datuk Nadzim Johan, an activist, the group’s had enough of government agencies keeping what they believe are safe and effective medicines from the people during the pandemic. In this nation of 33 million people, about 711,000 cases of SARS-CoV-2 have been recorded along with approximately 4,600 deaths.
While TrialSite reported recently that the health ministry and the Institute for Clinical Research commenced a 500 patient clinical trial investigating ivermectin for high-risk COVID-19 patients at 12 public hospitals, the Malaysian consumer and health activists argue that “Numerous clinical trials have proven that Ivermectin is able to reduce the risk of infection at 88 percent and reduce the fatality rate at 83 percent, many prophylaxes have also confirmed it can reduce Covid-19 transmissions.”
Mr. Nadzim cal...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).